This guide is written for pharmaceutical companies, startups, contract or loan-licence applicants, foreign investors, NRIs, OCIs, and businesses entering the Indian market. The licence exists to protect product quality and patient safety while giving your business legal access to the market.
Here's the catch: this framework is one of the most misunderstood areas of Indian pharma compliance. Requirements shift depending on drug category, manufacturing model, premises ownership, and which licensing authority has jurisdiction. Below, we walk through the 2026 process, documentation, costs, inspections, renewal, and the compliance obligations that continue long after approval.
Key Takeaways
- No single "drug manufacturing licence" covers every case: the route depends on drug category, schedule, and manufacturing model.
- Applications may go to the State Drugs Control Administration, CDSCO, or both, depending on the product.
- Compliant premises, Schedule M/GMP readiness, and qualified technical staff drive approval decisions.
- After approval, records, inspections, and renewals still need ongoing attention.
What Is a Drug Manufacturing Licence and Why Is It Required in India?
Under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945, a manufacturing licence is permission to manufacture specified drugs at an approved facility for sale or distribution. Without it, manufacturing is illegal, regardless of intent or product quality.
The licence exists to confirm one thing: that your facility, personnel, equipment, manufacturing controls, testing capability, storage, and records meet the standards prescribed under the Act and Rules — including the revised Schedule M good manufacturing practice (GMP) requirements.
How This Differs From Other Permissions
Businesses frequently confuse a manufacturing licence with related approvals:
- Wholesale or retail sale licence — authorises selling drugs, not making them.
- Product approval — clears a specific formulation; separate from facility authorisation.
- Loan licence — permits manufacturing at another licensee's approved facility.
- Test licence — allows manufacture solely for examination or analysis, not commercial sale.
- Cosmetic manufacturing licence — governs cosmetics, a distinct category from drugs.
- Medical-device permission — falls under separate device rules, not drug licensing.
- Business/company registration — establishes your legal entity but grants no manufacturing rights at all.
The Cost of Skipping the Licence
Manufacturing without the correct licence is a criminal offence under the Act.
Section 27(b)(ii) prescribes imprisonment of not less than three years and up to five years, plus a fine of at least ₹1 lakh or three times the value of the confiscated drugs, whichever is greater. Courts may reduce that only for recorded, special reasons. The penalty structure is set out in the Drugs and Cosmetics Act, 1940.
Beyond legal exposure, unlicensed manufacturing blocks commercial access entirely. Institutional buyers, distributors, and export partners typically demand licence proof before onboarding a supplier, and quality audits will flag the absence immediately.
A quick note on timing: revised Schedule M compliance dates have shifted more than once, most recently through phased applicability by turnover threshold. Confirm the current position with CDSCO or your regulatory advisor before filing, as 2026 updates continue to refine categories and timelines.
Types, Eligibility, and Licensing Authorities for Drug Manufacturing
India's manufacturing licence system is a set of routes tied to drug classification and manufacturing activity.
| Proposed Activity | Application Form | Resulting Licence |
|---|---|---|
| Ordinary drugs (outside Schedule C, C(1), X) | Form 24 | Form 25 |
| Schedule C/C(1) drugs | Form 27 | Form 28 |
| Schedule X drugs (outside C/C(1)) | Form 24F | Form 25F |
| Loan manufacture — ordinary drugs | Form 24A | Form 25A |
| Loan manufacture — Schedule C/C(1) | Form 27A | Form 28A |
| Repacking eligible drugs | Form 24B | Form 25B |
| Manufacture for test/examination only | Form 30 | Form 29 |
| Vaccines, sera, biologics, recombinant products | Form 27D (or 27DA for loan route) | Form 28D or 28DA |
Choosing the Right Route
Work through these questions before you file anything:
- Is the drug biological or non-biological?
- Does it fall under Schedule C, C(1), or X?
- What's the dosage form, and what manufacturing activity are you actually performing?
- Will you own the facility, or manufacture through someone else's approved premises?
Who grants the licence: State-appointed Drug Licensing Authorities handle most ordinary manufacturing applications. Specialised categories (vaccines, biologics, certain new drugs) involve CDSCO and a Central Licence Approving Authority alongside the state authority. New-drug permissions through CDSCO's SUGAM portal are an extra central step, not a substitute for the state manufacturing licence.
Loan Licences: What They Actually Require
A loan licence lets you manufacture using another licensee's facilities without owning your own plant. But it's still your licence, and it requires:
- A valid manufacturing agreement defining responsibilities
- Confirmed access to the host's approved facility and equipment
- Clear allocation of manufacturing and testing duties
- Continuing accountability for the products made under the arrangement: the host's licence does not shift liability away from you
Eligibility Basics
Across nearly all routes, authorities expect:
- A legally constituted applicant entity
- Suitable premises with approved equipment
- Qualified technical and competent staff
- Functioning quality-control systems and suitable storage
- Complete regulatory declarations and legal compliance
For foreign investors, NRIs, and OCIs: The drug licence usually sits alongside corporate incorporation, foreign investment approvals, tax registrations, employment compliance, and environmental clearances. None of those steps are handled by the drug licensing authority.
VJM Global coordinates India business setup, entity structuring, and cross-border compliance so the corporate side is ready while you pursue the licence through the competent drug authority.
Exact forms, fees, and authority routes vary by product and can change, so confirm current requirements with the relevant authority before you file.
How to Obtain a Drug Manufacturing Licence in India
The process runs in eight practical stages:
- Define your product and manufacturing model. Identify dosage forms, ingredients, schedules, biological status, and whether you'll manufacture in-house or through a loan/contract facility.
- Confirm the competent authority. Check the relevant State Drug Control portal or CDSCO's ONDLS system for the applicable form, fees, and document formats.
- Prepare the premises and manufacturing system. Your site needs proper layout, segregation, utilities, equipment, sanitation, storage, and quality-control arrangements aligned with Schedule M/GMP.
- Appoint qualified technical personnel. Document their qualifications, registrations, and manufacturing/quality-control responsibilities.
- Assemble and submit the application. Include product lists, site documents, ownership/lease evidence, technical-staff records, equipment details, and category-specific attachments.
- Prepare for scrutiny and inspection. Officials review documents, inspect premises, examine equipment and records, and assess testing capability — often issuing observations that require correction.
- Respond to deficiencies and obtain the licence. Approval depends on satisfying every observation. Once issued, check the licence covers the correct products, dosage forms, and premises.
- Plan post-approval operations. Batch documentation, testing, approved labelling, storage, inspection readiness, and renewal all start immediately after grant.
Delays That Are Entirely Avoidable
Most rejections and delays trace back to the same handful of mistakes:
- Filing under the wrong licence category
- Incomplete product information
- Premises documents that don't match the application
- Technical staff who are unqualified or simply unavailable during inspection
- GMP readiness gaps discovered only at inspection time
- Missing consent agreements for loan-licence arrangements
- Inconsistent data across portal submissions
- No response, or a slow response, to inspection observations
Documents, Premises, and Technical Requirements
Documentation requirements split into universal items and product- or authority-specific attachments.
Core Document Groups
- Incorporation or constitution documents and authorised-signatory proof
- Premises ownership or lease documents, plus site plan and layout
- Machinery and equipment list
- Technical-staff qualification and experience records
- Laboratory and testing details
- Product and formula information
- Quality-control procedures and standard operating procedures
- Declarations and applicable consent or no-objection documents
For Loan and Third-Party Manufacturing
If you're applying under a loan-licence arrangement, the manufacturing agreement is the single most scrutinised document. It needs to define:
- Consent of the facility owner
- Allocation of manufacturing versus testing responsibility
- Batch-release arrangements
- Records access for both parties
- Confidentiality, complaints, recall, and termination provisions
A rented or outsourced facility is not automatically compliant just because another business already holds a licence for it. The applicant's own responsibilities still need to be documented and demonstrated.
Facility Expectations in Practice
Inspectors look for:
- Construction and workflow that prevents contamination and product mix-ups
- Appropriate utilities, including HVAC or water systems where relevant
- Sanitation and waste-handling controls
- Dedicated testing areas with calibrated, validated equipment
- Worker safety measures
The revised Schedule M requires a documented pharmaceutical quality system covering premises, equipment, personnel training, hygiene, production controls, and record-keeping, as set out in the CDSCO Drugs Rules compilation. Sterile manufacturing carries additional controls beyond the general requirements. Always verify the current checklist with your state authority rather than working from an outdated list.
Costs, Validity, Renewal, and Common Compliance Issues
What You're Actually Paying For
Government fees are only one line item. The full cost picture includes:
- Application and inspection fees (form-specific)
- Facility preparation and GMP upgrades
- Testing and validation costs
- Technical personnel salaries
- Documentation and professional support
- Agreement drafting costs for loan arrangements
| Application | Statutory Fee (as per Rules) |
|---|---|
| Form 24 (ordinary manufacturing) | ₹6,000 licence fee + ₹1,500 inspection fee |
| Form 24A (ordinary loan licence) | ₹6,000 + ₹1,500 inspection fee |
| Form 24B (repacking) | ₹500 + ₹200 inspection fee |
| Form 30 (test licence application) | ₹250 |
These figures come from the official Rules compilation and don't account for state-specific additions, product-count surcharges, or the 2026 fee position. Confirm current amounts before budgeting.
Validity and Renewal
Manufacturing licences aren't renewed annually by default. Retention fees are payable at prescribed intervals, and late payment attracts a 2% per month penalty for up to six months, after which the licence can be treated as cancelled.
Test licences under Form 29 follow a different cycle: an initial three-year term with annual renewal. According to a Press Information Bureau update on drug compliance enforcement, regulators have conducted over 960 risk-based inspections and taken more than 860 enforcement actions in recent years. Inspection activity does not stop once a licence is granted.
What Triggers an Amendment
Post-licence, you'll need fresh approvals for:
- New products or dosage forms
- Changed premises
- New technical staff
- Ownership or manufacturing-arrangement changes
- Equipment additions
Common Misconceptions
- A company incorporation certificate is not a drug manufacturing licence.
- CDSCO doesn't issue every manufacturing permission; many sit entirely with state authorities.
- A wholesale or retail licence doesn't authorise manufacturing.
- A third-party manufacturing agreement doesn't remove your own regulatory responsibility.
When This Isn't the Right Route
Skip the standard manufacturing licence process if you're:
- Manufacturing solely for testing (you need a Form 30/29 test licence instead)
- Producing cosmetics or medical devices, which fall under separate rules
- Only planning to sell, not manufacture (wholesale/retail licence applies)
Once your product route is confirmed, surrounding business compliance still needs handling: GST, ROC filings, FEMA/FDI reporting for foreign capital, and payroll. This is the layer VJM Global supports for foreign businesses building an India presence, while product-specific licensing decisions stay with the competent drug authority or a specialised regulatory consultant.
Conclusion
Securing a drugs manufacturing licence in India depends on getting each stage right:
- Match the licence route to your product and business model
- Build a compliant facility and technical team
- Submit accurate documentation and clear inspection
- Maintain compliance after approval
Skip any one of these and you risk delays or outright rejection.
Fees, forms, authorities, and GMP expectations change over time. Confirm the current 2026 position from official sources before you file.
If you're entering India from abroad, assess your regulatory route early and align corporate setup, facility readiness, and documentation from the start. Treat the licence as an ongoing compliance relationship rather than a one-time submission.
Frequently Asked Questions
How much does a drug licence cost in India?
Cost depends on licence type, product category, number of products, and facility readiness. Statutory fees range from ₹250 to ₹6,000+ per form, but check the current official fee schedule before budgeting for total costs.
How do I get a drug manufacturing licence in India?
Classify your product, identify the competent authority, prepare compliant premises and technical staff, submit documentation, and clear inspection. The licence is issued once all observations are resolved.
Who is eligible to get a drug licence in India?
Any legally constituted entity with compliant premises, qualified personnel, working equipment, and quality-control systems can apply. Exact eligibility conditions vary by licence type and drug category.
How do I get a wholesale drug licence in India?
A wholesale licence authorises sale, not manufacturing, and is applied for separately through the State Drug Control authority with premises, a competent person, and record-keeping requirements in place.
What's the difference between a wholesale and a retail drug licence?
Wholesale permissions cover supply to authorised businesses or institutions; retail permissions cover direct sale to consumers. Each carries different premises, supervision, and record requirements.
What is the Drugs and Cosmetics Act in India?
It's the principal law governing drug and cosmetic manufacture, sale, and distribution in India, supported by the Drugs Rules, 1945 and associated schedules covering quality, labelling, and licensing.
